Pegaspargase Interactions
There are 531 drugs known to interact with pegaspargase, along with 4 disease interactions, and 1 alcohol/food interaction. Of the total drug interactions, 44 are major, and 487 are moderate.
- View all 531 medications that may interact with pegaspargase
- View pegaspargase alcohol/food interactions (1)
- View pegaspargase disease interactions (4)
Most frequently checked interactions
View interaction reports for pegaspargase and the medicines listed below.
- Activated Charcoal (charcoal)
- Activated Charcoal (charcoal)
- Alcohol (contained in alcoholic beverages) (ethanol)
- Alcohol (contained in alcoholic beverages) (ethanol)
- Alimta (pemetrexed)
- Alimta (pemetrexed)
- Alka-Seltzer Original (aspirin/citric acid/sodium bicarbonate)
- Alka-Seltzer Original (aspirin/citric acid/sodium bicarbonate)
- Anti-D (RHO) Immunoglobulin (rho (d) immune globulin)
- Anti-D (RHO) Immunoglobulin (rho (d) immune globulin)
- Ativan (lorazepam)
- Ativan (lorazepam)
- Bactrim (sulfamethoxazole / trimethoprim)
- Bactrim (sulfamethoxazole / trimethoprim)
- Benadryl (diphenhydramine)
- Benadryl (diphenhydramine)
- Co-trimoxazole (sulfamethoxazole / trimethoprim)
- Co-trimoxazole (sulfamethoxazole / trimethoprim)
- Demerol (meperidine)
- Demerol (meperidine)
- Paracetamol (acetaminophen)
- Paracetamol (acetaminophen)
- Protonix (pantoprazole)
- Protonix (pantoprazole)
- Retinol (vitamin a topical)
- Retinol (vitamin a topical)
- Tabloid (thioguanine)
- Tabloid (thioguanine)
- Zofran (ondansetron)
- Zofran (ondansetron)
Pegaspargase alcohol/food interactions
There is 1 alcohol/food interaction with pegaspargase.
Pegaspargase disease interactions
There are 4 disease interactions with pegaspargase which include:
Report options
More about pegaspargase
- pegaspargase consumer information
- Compare alternatives
- Reviews (2)
- Side effects
- Dosage information
- During pregnancy
- Drug class: miscellaneous antineoplastics
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Gleevec
Gleevec is targeted cancer therapy for specific types of leukemia (blood cancer), bone marrow ...
Sprycel
Sprycel is used to treat chronic myeloid leukemia and acute lymphoblastic leukemia. Learn about ...
Dupixent
Dupixent is used to treat eczema, eosinophilic or oral-corticosteroid-dependent asthma, chronic ...
Adriamycin
Adriamycin is used for acute lymphoblastic leukemia, acute myeloblastic leukemia, bladder cancer ...
Ponatinib
Ponatinib is used to treat chronic myeloid leukemia and Philadelphia chromosome positive acute ...
Blinatumomab
Blinatumomab (Blincyto) is an injectable immunotherapy treatment that may be used to treat B-cell ...
Mercaptopurine
Mercaptopurine is used for acute lymphoblastic leukemia, autoimmune hepatitis, crohn's disease ...
Dasatinib
Dasatinib is used to treat Philadelphia chromosome-positive chronic myelogenous leukemia (CML) ...
Imatinib
Imatinib is used to treat certain types of leukemia, bone marrow disorders, and skin cancer ...
Doxorubicin
Doxorubicin is used for acute lymphoblastic leukemia, acute myeloblastic leukemia, bladder cancer ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.